The recent declaration of COVID-19 as a global pandemic by the World Health Organisation has prompted us to make the relevant Data, Research and Resources at the Vinod Scaria Lab at CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) in an open format to ensure that they are widely accessible as well as relevant. The programme would embrace the concepts of open-source and open access.
genepi-box is an automated computational resource for assembly, analysis and sharing of pathogen genomic data including for SARS-CoV-2.
The resource is built keeping in mind resource limitations in bioinformatics analysis of pathogen genomes.
The unique partnership between the Department of Health & Family Welfare, Government of Kerala, National health Mission Kerala, CSIR Institute of Genomics & Integrative Biology (CSIR-IGIB) and various clinical and public health centers in Kerala aimed at providing insights into the genetic epidemiology of COVID-19 in Kerala
The initiative of Public Health relevance involves 12 Govt Medical Colleges, State Public Health & Regional Laboratories, Inter-University Centre for Biomedical Research, Central University of Kerala& 14 District Surveillance Units
Research at the COVID-19 Open featured in News and Media
India’s Covid-19 Numbers Have Fallen. A Third Wave Still Looms NYT 17/08/2021
‘Delta, lineages can’t fully escape immunity, make vax a priority’ ToI 17/08/2021
COVID Data - Open to all Mid-Day 27/12/2020
21 experts you should follow if you want to make sense of the pandemic ZME Science 28/09/2020
Two asymptomatic healthcare workers reinfected with Covid-19 Deccan Herald 14/08/2020
Coronavirus strain predominant in India originated in Europe Rediff 03/09/2020
Open Minds 2020 : Mind over Matter OPEN 31/07/2020
Slight genetic changes of virus don't change strain, say geneticists Business Standard 14/08/2020
COVID-19 Response: Young Scientists Are Among India’s Unsung Heroes The Wire 23/06/2020
Family portrait of novel coronavirus reveals a new type in India The Federal 7/06/2020
India to have own genome data bank to decode COVID-19 virus The New Indian Express 12/06/2020
New data to understand virus origin, mutation The New Indian Express 27/05/2020
An asset to a pandemic PhDs of India 02/06/2020
Researchers in the UK had just set the scientific world ablaze with news that a covid variant called B.1.1.7—soon to be referred to as alpha—was to blame for skyrocketing case counts there. Jolly, a third-year PhD student at the CSIR Institute of Genomics and Integrative Biology in New Delhi, expected to find that it was driving infections in her country too.
Read more: https://www.technologyreview.com/2021/07/26/1030017/covid-variants-pangolin-pango-volunteers/
The danger of new virus variants highlights the importance of keeping a close watch on them. That’s where genomic surveillance helps. Using scientific and technological tools — from virtual networks to GitHub pages — researchers are sharing their updates and building genomic databanks to gain an upper hand on the virus and sharpen the weapons to fight it.
Vinod Scaria, principal scientist at Delhi-based CSIR-IGIB, and Bani Jolly, a graduate student at the same institution, are among a score of scientists from various laboratories who have been involved in the genome sequencing effort in India.
The following Projects are open and currently underway. The datasets and results are also listed appropriately.
The COVID-19 Reinfections observatory aims to compile information on COVID-19 reinfections from across the world as a ready reference. The programme also provides an opportunity to refer potential cases for genomic verification.
The LongCOVID India initiative provides a platform for participatory and collaborative research on LongCOVID in India.
The aim of the project would be to compile all primers/probes for screening and diagnosis of SARS CoV-2 infection from across the world.
The aim of the project is to use public data of SARS CoV-2 genomes for understanding the genetic epidemiology of the epidemic.
COVID19CONNECT is an application integrating recent information, resources and a platform to connect citizens, patients, clinicians and researchers during the COVID19 epidemic in India. [Mobile App for Android] [Web Application]
The COVID-19 and Rare Diseases initiative aims to quantify the effect of COVID-19 on Rare Disease patients.